Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation | |
---|---|---|
D003141 | Communicable Diseases NIH | 0.07 |
D007239 | Infection NIH | 0.05 |
Name (Synonyms) | Correlation |
---|
Navigate: Correlations HPO
There is one clinical trial.
The ongoing coronavirus disease 2019 (COVID-19) which started in China, was declared on the 11th of March as a global pandemic 2020 by the World Health Organization (WHO). Governments around the world have introduced differing forms of lock downs since the start of the pandemic demanding citizens to confine to their homes and go out only in necessity to minimize exposure to the virus. The response was observed in the emergency departments and the number of patients who presented for non-Covid issues drastically reduced. Hospitals activated their mass casualty management plans and have reorganized and overstretched their capacity to be able to absorb both the influx of patients with the virus and those with other conditions. Part of that reorganization was reducing the surgical activity. The main focus was shifted to patients who are considered urgent and elective surgery were postponed. Hence only surgical emergencies were maintained. Many did not present to the emergency department for fear to contract the virus and from a sense of national and global solidarity against that pandemic. Whereas these measures are essential to prevent the spread of the virus, it may be hypothesized that for non-Covid issues, including surgical emergencies, patients may present late to the emergency department due to fear of contracting the infection in hospital. This would delay their management and lead to a worsened symptomology on presentation requiring a more complex surgical intervention with an increased complication profile. The investigators present initial data from four major hospitals in Belgium, characterizing surgical emergencies that were managed since the start of the pandemic and discuss the repercussion the pandemic has on management of urgent surgical patients and most likely evolution of surgery after the pandemic.
Description: Type of surgery as defined by the surgery code
Measure: Surgery code Time: 5 minutesDescription: Degree of urgency of the surgery
Measure: Urgency Time: 5 minutesDescription: Type of anesthesia
Measure: Type of anesthesia Time: 5 minutesDescription: Delay between surgery and first symptoms
Measure: Delay between surgery and first symptoms Time: 5 minutesDescription: Surgery duration (anesthesia included)
Measure: Surgery duration Time: 5 minutesDescription: Hospital stay (in days)
Measure: Hospital stay (in days) Time: 5 minutesDescription: Intensive care unit stay (in days)
Measure: Intensive care unit stay (in days) Time: 5 minutesDescription: Post-op complications
Measure: Post-op complications Time: 5 minutesDescription: Covid status before surgery (positive=1, negative=0 )
Measure: Covid status before surgery Time: 5 minutesDescription: Covid status post-op (positive=1, negative=0 )
Measure: Covid status post-surgery Time: 5 minutesDescription: COVID19 Diagnosis confirmed by CT scan of the thorax (Yes=1, No=0)
Measure: COVID19 Diagnosis by CT scan Time: 5 minutesDescription: COVID19 Diagnosis by swab test (Yes=1, No=0)
Measure: COVID19 Diagnosis by swab test Time: 5 minutesDescription: COVID 19 Diagnosis by antibody test (Yes=1, No=0)
Measure: COVID 19 Diagnosis by antibody test Time: 5 minutesDescription: dry cough (Yes=1, No=0)
Measure: COVID19 symptoms - dry cough Time: 5 minutesDescription: fever (Yes=1, No=0)
Measure: COVID19 symptoms - fever Time: 5 minutesDescription: myalgia (Yes=1, No=0)
Measure: COVID19 symptoms - myalgia Time: 5 minutesDescription: anosmia (Yes=1, No=0)
Measure: COVID19 symptoms - anosmia Time: 5 minutesDescription: respiratory distress (Yes=1, No=0)
Measure: COVID19 symptoms -respiratory distress Time: 5 minutesDescription: Plaquenil (Yes=1, No=0)
Measure: Treatment for COVID19 - Plaquenil Time: 5 minutesDescription: Antivirals (Yes=1, No=0)
Measure: Treatment for COVID19 - Antivirals Time: 5 minutesDescription: Need for intubation (Yes=1, No=0)
Measure: Need for intubation Time: 5 minutesDescription: Mortality (Yes=1, No=0)
Measure: Death Time: 5 minutesDescription: Patient age
Measure: Age Time: 5 minutesDescription: Patient gender
Measure: Gender Time: 5 minutesDescription: Patient ethnicity
Measure: Ethnicity Time: 5 minutesDescription: Patient Body Mass Index
Measure: BMI Time: 5 minutesDescription: Patient comorbidities
Measure: Comorbidities Time: 5 minutesAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports